Preliminary Preclinical Data Demonstrates In Vivo Proof-of-Concept for Novel Diabetes Gene Therapy in Type 2 Diabetic Non-Human Primates GPX-002 Rejuvenated Exhausted ...
Genprex, Inc. ("Genprex" or the "Company") , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced preliminary in ...
Understanding why cancer cells rely on specific genes is critical for designing effective targeted therapies. A new study ...
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions The latest update is out from Genprex ( (GNPX) ). On January 6, 2026, Genprex reported positive preliminary ...
Capricor Therapeutics recently more than tripled on positive Phase 3 HOPE-3 data for deramiocel in Duchenne muscular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback